Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Using machine learning to generate high-resolution wet area maps for planning forest management: A study in a boreal forest landscape.

Lidberg W, Nilsson M, Ågren A.

Ambio. 2019 May 9. doi: 10.1007/s13280-019-01196-9. [Epub ahead of print]

PMID:
31073983
2.

Correlation of thromboelastography and thrombin generation assays in warfarin-treated patients.

Schmidt DE, Chaireti R, Bruzelius M, Holmström M, Antovic J, Ågren A.

Thromb Res. 2019 Jun;178:34-40. doi: 10.1016/j.thromres.2019.03.022. Epub 2019 Apr 1.

PMID:
30959280
3.

Experimental crossbreeding reveals strain-specific variation in mortality, growth and personality in the brown trout (Salmo trutta).

Ågren A, Vainikka A, Janhunen M, Hyvärinen P, Piironen J, Kortet R.

Sci Rep. 2019 Feb 26;9(1):2771. doi: 10.1038/s41598-018-35794-6.

4.

Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin-based trigger.

Taune V, Skeppholm M, Ågren A, Gryfelt G, Malmström RE, Wikman A, Van Ryn J, Wallén H.

J Thromb Haemost. 2018 Dec;16(12):2462-2470. doi: 10.1111/jth.14308. Epub 2018 Nov 1.

PMID:
30288934
5.

Fifth Åland Island conference on von Willebrand disease.

Berntorp E, Ågren A, Aledort L, Blombäck M, Cnossen MH, Croteau SE, von Depka M, Federici AB, Goodeve A, Goudemand J, Mannucci PM, Mourik M, Önundarson PT, Rodeghiero F, Szántó T, Windyga J.

Haemophilia. 2018 May;24 Suppl 4:5-19. doi: 10.1111/hae.13475.

PMID:
29687935
6.

Tilltagande anemi och trombocytopeni hos gravida kan vara trombotisk trombocytopen purpura.

Ågren A, Antovic J, Strandberg K, Frisk T, Löfstedt P, Strindfors G, Celsing F.

Lakartidningen. 2018 Mar 16;115. pii: EYWT. Swedish. No abstract available.

7.

Identifying and assessing the potential hydrological function of past artificial forest drainage.

Hasselquist EM, Lidberg W, Sponseller RA, Ågren A, Laudon H.

Ambio. 2018 Sep;47(5):546-556. doi: 10.1007/s13280-017-0984-9. Epub 2017 Nov 2.

8.

Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study.

Majeed A, Ågren A, Holmström M, Bruzelius M, Chaireti R, Odeberg J, Hempel EL, Magnusson M, Frisk T, Schulman S.

Blood. 2017 Oct 12;130(15):1706-1712. doi: 10.1182/blood-2017-05-782060. Epub 2017 Aug 23.

PMID:
28835439
9.

Whole blood ristocetin-activated platelet impedance aggregometry (Multiplate) for the rapid detection of Von Willebrand disease.

Schmidt DE, Bruzelius M, Majeed A, Odeberg J, Holmström M, Ågren A.

Thromb Haemost. 2017 Jul 26;117(8):1528-1533. doi: 10.1160/TH17-02-0129. Epub 2017 Jul 6.

PMID:
28692107
10.

Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).

Grosso G, Vikerfors A, Woodhams B, Adam M, Bremme K, Holmström M, Ågren A, Eelde A, Bruzelius M, Svenungsson E, Antovic A.

Thromb Res. 2017 Oct;158:168-173. doi: 10.1016/j.thromres.2017.06.028. Epub 2017 Jun 24.

PMID:
28669410
11.

Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma.

Schmidt DE, Halmin M, Wikman A, Östlund A, Ågren A.

Scand J Clin Lab Invest. 2017 Oct;77(6):397-405. doi: 10.1080/00365513.2017.1334128. Epub 2017 Jun 20.

PMID:
28632435
12.

What are we talking about? Constructions of loneliness among older people in the Swedish news-press.

Agren A.

J Aging Stud. 2017 Apr;41:18-27. doi: 10.1016/j.jaging.2017.03.002. Epub 2017 Mar 19.

PMID:
28610751
13.

Thromboelastometry: Relation to the severity of liver cirrhosis in patients considered for liver transplantation.

Dumitrescu G, Januszkiewicz A, Ågren A, Magnusson M, Wahlin S, Wernerman J.

Medicine (Baltimore). 2017 Jun;96(23):e7101. doi: 10.1097/MD.0000000000007101. Erratum in: Medicine (Baltimore). 2017 Jun 30;96(26):e7420.

14.

Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment.

Taune V, Wallén H, Ågren A, Gryfelt G, Sjövik C, Wintler AM, Malmström RE, Wikman A, Skeppholm M.

Thromb Res. 2017 May;153:76-82. doi: 10.1016/j.thromres.2017.03.018. Epub 2017 Mar 18.

PMID:
28347811
15.

A prospective diagnostic accuracy study evaluating rotational thromboelastometry and thromboelastography in 100 patients with von Willebrand disease.

Schmidt DE, Majeed A, Bruzelius M, Odeberg J, Holmström M, Ågren A.

Haemophilia. 2017 Mar;23(2):309-318. doi: 10.1111/hae.13121. Epub 2016 Oct 26.

PMID:
27785858
16.

Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.

Ågren A, Holmström M, Schmidt DE, Hosokawa K, Blombäck M, Hjemdahl P.

Thromb Haemost. 2017 Jan 5;117(1):75-85. doi: 10.1160/TH16-06-0430. Epub 2016 Oct 20.

PMID:
27761577
17.

Haemostasis monitored in stored red blood cells, plasma and platelet concentrates in the proportion of 4 :  4 :  1 diluted with crystalloids and colloids.

Ågren A, Edgren G, Ambrosio D, Gryfelt G, Östlund A, Wikman A.

Blood Coagul Fibrinolysis. 2016 Apr;27(3):334-9. doi: 10.1097/MBC.0000000000000433.

PMID:
26963027
18.

The role of biogeochemical hotspots, landscape heterogeneity, and hydrological connectivity for minimizing forestry effects on water quality.

Laudon H, Kuglerová L, Sponseller RA, Futter M, Nordin A, Bishop K, Lundmark T, Egnell G, Ågren AM.

Ambio. 2016 Feb;45 Suppl 2:152-62. doi: 10.1007/s13280-015-0751-8.

19.

The temporal pattern of postoperative coagulation status in patients undergoing major liver surgery.

Dumitrescu G, Januszkiewicz A, Ågren A, Magnusson M, Isaksson B, Wernerman J.

Thromb Res. 2015 Aug;136(2):402-7. doi: 10.1016/j.thromres.2015.05.023. Epub 2015 May 24.

20.

Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves.

Schulman JM, Majeed A, Mattsson E, Schulman S, Holmström M, Ågren A.

J Thromb Thrombolysis. 2015 Nov;40(4):430-6. doi: 10.1007/s11239-015-1216-4.

PMID:
25868460
21.

Relationship between structural features and water chemistry in boreal headwater streams--evaluation based on results from two water management survey tools suggested for Swedish forestry.

Lestander R, Löfgren S, Henrikson L, Ågren AM.

Environ Monit Assess. 2015 Apr;187(4):190. doi: 10.1007/s10661-015-4385-x. Epub 2015 Mar 19.

22.

Detection of elevated INR by thromboelastometry and thromboelastography in warfarin treated patients and healthy controls.

Schmidt DE, Holmström M, Majeed A, Näslin D, Wallén H, Ågren A.

Thromb Res. 2015 May;135(5):1007-11. doi: 10.1016/j.thromres.2015.02.022. Epub 2015 Feb 26.

PMID:
25746367
23.

[Sickle cell anemia causes varied symptoms and high morbidity. Serious prognosis in the most common genetic disease in the world].

Kjellander C, Sennström MK, Stiller V, Ågren A.

Lakartidningen. 2015 Mar 3;112. pii: DCPM. Review. Swedish.

24.

In response.

Agren A, Wikman A, Ostlund A, Edgren G.

Anesth Analg. 2014 Dec;119(6):1453. doi: 10.1213/ANE.0000000000000431. No abstract available.

PMID:
25405698
25.

Gene-Lifestyle Interactions in Complex Diseases: Design and Description of the GLACIER and VIKING Studies.

Kurbasic A, Poveda A, Chen Y, Agren A, Engberg E, Hu FB, Johansson I, Barroso I, Brändström A, Hallmans G, Renström F, Franks PW.

Curr Nutr Rep. 2014 Dec 1;3(4):400-411.

26.

Response to comment on Ågren et al. Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes. Diabetes care 2014;37:2007-2014.

Agren A, Jörneskog G, Elgue G, Henriksson P, Wallen H, Wiman B.

Diabetes Care. 2014 Nov;37(11):e244. doi: 10.2337/dc14-1644. No abstract available.

PMID:
25342841
27.

Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.

Tehrani S, Jörneskog G, Ågren A, Lins PE, Wallén H, Antovic A.

Thromb Haemost. 2015 Feb;113(2):312-8. doi: 10.1160/TH14-05-0404. Epub 2014 Oct 16.

PMID:
25318636
28.

In vitro combinations of red blood cell, plasma and platelet components evaluated by thromboelastography.

Agren A, Edgren G, Kardell M, Ostlund A, Wikman AT.

Blood Transfus. 2014 Oct;12(4):491-6. doi: 10.2450/2014.0285-13. Epub 2014 Jun 5.

29.

Groundwater discharge creates hotspots of riparian plant species richness in a boreal forest stream network.

Kuglerová L, Jansson R, Agren A, Laudon H, Malm-Renöfält B.

Ecology. 2014 Mar;95(3):715-25.

PMID:
24804455
30.

TEG® functional fibrinogen analysis may overestimate fibrinogen levels.

Agren A, Wikman AT, Ostlund A, Edgren G.

Anesth Analg. 2014 May;118(5):933-5. doi: 10.1213/ANE.0000000000000172.

PMID:
24781565
31.

Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes.

Agren A, Jörneskog G, Elgue G, Henriksson P, Wallen H, Wiman B.

Diabetes Care. 2014 Jul;37(7):2007-14. doi: 10.2337/dc13-1776. Epub 2014 Apr 23.

PMID:
24760258
32.

Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome.

Vikerfors A, Svenungsson E, Ågren A, Mobarrez F, Bremme K, Holmström M, Eelde A, Bruzelius M, Elgue G, Wallén H, Antovic A.

Thromb Res. 2014 May;133(5):936-44. doi: 10.1016/j.thromres.2014.02.023. Epub 2014 Feb 28.

PMID:
24630645
33.

Evasion of CO2 from streams - the dominant component of the carbon export through the aquatic conduit in a boreal landscape.

Wallin MB, Grabs T, Buffam I, Laudon H, Agren Å, Öquist MG, Bishop K.

Glob Chang Biol. 2013 Mar;19(3):785-97. doi: 10.1111/gcb.12083. Epub 2012 Dec 15.

PMID:
23504836
34.

Thromboelastography (TEG®) compared to conventional coagulation tests in surgical patients--a laboratory evaluation.

Ågren A, Wikman AT, Holmström M, Östlund A, Edgren G.

Scand J Clin Lab Invest. 2013 Apr;73(3):214-20. doi: 10.3109/00365513.2013.765960. Epub 2013 Feb 12.

PMID:
23402666
35.

Studies of microparticles in patients with the antiphospholipid syndrome (APS).

Vikerfors A, Mobarrez F, Bremme K, Holmström M, Ågren A, Eelde A, Bruzelius M, Antovic A, Wallén H, Svenungsson E.

Lupus. 2012 Jun;21(7):802-5. doi: 10.1177/0961203312437809.

PMID:
22635239
36.

A case series of five episodes of massive LMWH non-fatal self-induced overdose in a single patient.

Odeberg J, Carlsson A, Hällsjö-Sander C, Agren A.

Thromb Res. 2012 May;129(5):668-70. doi: 10.1016/j.thromres.2011.12.033. Epub 2012 Jan 18. No abstract available.

PMID:
22261479
37.

Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy.

Majeed A, Eelde A, Agren A, Schulman S, Holmström M.

Thromb Res. 2012 Feb;129(2):146-51. doi: 10.1016/j.thromres.2011.07.024. Epub 2011 Jul 31.

PMID:
21807399
38.

[Life-saving transplantation in pregnancy-related liver failure. Well functioning care continuity contributed to the good result].

Agren A, Stål P, Agvald-Ohman C, Eleborg L, Nowak G, Ajne G.

Lakartidningen. 2011 Jan 19-26;108(3):92-5. Swedish. No abstract available.

PMID:
21381266
39.

Modelling the fate of hydrophobic organic contaminants in a boreal forest catchment: a cross disciplinary approach to assessing diffuse pollution to surface waters.

Bergknut M, Meijer S, Halsall C, Agren A, Laudon H, Köhler S, Jones KC, Tysklind M, Wiberg K.

Environ Pollut. 2010 Sep;158(9):2964-9. doi: 10.1016/j.envpol.2010.05.027. Epub 2010 Jul 8.

PMID:
20619517
40.

Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case-control study.

Berglin E, Kokkonen H, Einarsdottir E, Agren A, Rantapää Dahlqvist S.

Scand J Rheumatol. 2010 Nov;39(6):454-60. doi: 10.3109/03009741003742763. Epub 2010 Jun 21.

PMID:
20560812
41.

Region-specific nutrient intake patterns exhibit a geographical gradient within and between European countries.

Freisling H, Fahey MT, Moskal A, Ocké MC, Ferrari P, Jenab M, Norat T, Naska A, Welch AA, Navarro C, Schulz M, Wirfält E, Casagrande C, Amiano P, Ardanaz E, Parr C, Engeset D, Grioni S, Sera F, Bueno-de-Mesquita B, van der Schouw YT, Touvier M, Boutron-Ruault MC, Halkjaer J, Dahm CC, Khaw KT, Crowe F, Linseisen J, Kröger J, Huybrechts I, Deharveng G, Manjer J, Agren A, Trichopoulou A, Tsiotas K, Riboli E, Bingham S, Slimani N.

J Nutr. 2010 Jul;140(7):1280-6. doi: 10.3945/jn.110.121152. Epub 2010 May 19.

PMID:
20484545
42.

Response of dissolved organic carbon following forest harvesting in a boreal forest.

Laudon H, Hedtjärn J, Schelker J, Bishop K, Sørensen R, Agren A.

Ambio. 2009 Nov;38(7):381-6.

PMID:
19943394
43.

Specific food group combinations explaining the variation in intakes of nutrients and other important food components in the European Prospective Investigation into Cancer and Nutrition: an application of the reduced rank regression method.

Kröger J, Ferrari P, Jenab M, Bamia C, Touvier M, Bueno-de-Mesquita HB, Fahey MT, Benetou V, Schulz M, Wirfält E, Boeing H, Hoffmann K, Schulze MB, Orfanos P, Oikonomou E, Huybrechts I, Rohrmann S, Pischon T, Manjer J, Agren A, Navarro C, Jakszyn P, Boutron-Ruault MC, Niravong M, Khaw KT, Crowe F, Ocké MC, van der Schouw YT, Mattiello A, Bellegotti M, Engeset D, Hjartåker A, Egeberg R, Overvad K, Riboli E, Bingham S, Slimani N.

Eur J Clin Nutr. 2009 Nov;63 Suppl 4:S263-74. doi: 10.1038/ejcn.2009.85.

PMID:
19888278
44.

Circulating vitamin d and risk of epithelial ovarian cancer.

Arslan AA, Clendenen TV, Koenig KL, Hultdin J, Enquist K, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P, Lundin E.

J Oncol. 2009;2009:672492. doi: 10.1155/2009/672492. Epub 2009 Aug 27.

45.

Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns.

de-Wahl Granelli A, Wennergren M, Sandberg K, Mellander M, Bejlum C, Inganäs L, Eriksson M, Segerdahl N, Agren A, Ekman-Joelsson BM, Sunnegårdh J, Verdicchio M, Ostman-Smith I.

BMJ. 2009 Jan 8;338:a3037. doi: 10.1136/bmj.a3037.

46.

Low PAI-1 activity in relation to inflammatory parameters, insulin profile and body mass index.

Agren A, Wiman B, Schulman S.

J Intern Med. 2008 Dec;264(6):586-92. doi: 10.1111/j.1365-2796.2008.01999.x. Epub 2008 Sep 6.

47.

Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition.

Khan AE, Gallo V, Linseisen J, Kaaks R, Rohrmann S, Raaschou-Nielsen O, Tjønneland A, Johnsen HE, Overvad K, Bergmann MM, Boeing H, Benetou V, Psaltopoulou T, Trichopoulou A, Masala G, Mattiello A, Grioni S, Tumino R, Vermeulen RC, Peeters PH, Bueno-de-Mesquita HB, Ros MM, Lund E, Ardanaz E, Chirlaque MD, Jakszyn P, Larrañaga N, Losada A, Becker N, Nieters A, Martínez-García C, Agren A, Hallmans G, Berglund G, Manjer J, Allen NE, Key TJ, Bingham S, Khaw KT, Slimani N, Ferrari P, Boffetta P, Norat T, Vineis P, Riboli E; EPIC Group.

Haematologica. 2008 Jun;93(6):842-50. doi: 10.3324/haematol.12297. Epub 2008 Apr 28.

48.

["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].

Wallén H, Agren A, Nekludov M.

Lakartidningen. 2007 Nov 28-Dec 4;104(48):3640-2. Swedish. No abstract available.

PMID:
18193674
49.

Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer.

Clendenen TV, Arslan AA, Koenig KL, Enquist K, Wirgin I, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P, Lundin E.

Cancer Lett. 2008 Feb 18;260(1-2):209-15.

50.

Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.

Agren A, Wiman B, Schulman S.

Blood Coagul Fibrinolysis. 2007 Oct;18(7):657-60.

PMID:
17890953

Supplemental Content

Support Center